{
  "request": {
    "url": "https://query2.finance.yahoo.com/v10/finance/quoteSummary/ABBV?formatted=false&modules=summaryProfile&crumb=haT3oykhHqZ",
    "method": "GET",
    "headers": {
      "cookie": "GUCS=AV78X-IQ; GUC=AQABCAFnsytn2UIgTASn&s=AQAAAEKG89vA&g=Z7HctQ; A3=d=AQABBKvcsWcCEIGLkyl67hr2YX7XekV46j4FEgABCAErs2fZZ_bPb2UB9qMAAAcIq9yxZ63aZoI&S=AQAAAtFJa---IoVh8DRgGhGzVr4; A1S=d=AQABBKvcsWcCEIGLkyl67hr2YX7XekV46j4FEgABCAErs2fZZ_bPb2UB9qMAAAcIq9yxZ63aZoI&S=AQAAAtFJa---IoVh8DRgGhGzVr4; EuConsent=CQM66kAQM66kAAOACBENBcFoAP_gAEPgACiQKptB9G7WTXFneXp2YPskOYUX0VBJ4MAwBgCBAcABzBIUIBwGVmAzJEyIICACGAIAIGBBIABtGAhAQEAAYIAFAABIAEgAIBAAIGAAACAAAABACAAAAAAAAAAQgEAXMBQgmAYEBFoIQUhAggAgAQAAAAAEAIgBCgQAEAAAQAAICAAIACgAAgAAAAAAAAAEAFAIEQAAIAECAotkdQAAAAAAAAAAAAQACAABAAAAAIKpgAkGpUQBFgSEhAIGEECAEQUBABQIAgAACBAAAATBAUIAwAVGAiAEAIAAAAAAAAACABAAABAAhAAEAAQIAAAAAIAAgAIBAAACAAAAAAAAAAAAAAAAAAAAAAAAAGIBAggAAABBAAQUAAAAAgAAAAAAAAAIgACAAAAAAAAAAAAAAIgAAAAAAAAAAAAAAAAAAIAAAAIAAAAgBEFgAAAAAAAAAAAAAACAABAAAAAIAAA; A1=d=AQABBKvcsWcCEIGLkyl67hr2YX7XekV46j4FEgABCAErs2fZZ_bPb2UB9qMAAAcIq9yxZ63aZoI&S=AQAAAtFJa---IoVh8DRgGhGzVr4",
      "user-agent": "@gadicc/yahoo-finance2/0.0.1 (+https://github.com/gadicc/node-yahoo-finance2)"
    }
  },
  "response": {
    "ok": true,
    "status": 200,
    "statusText": "OK",
    "headers": {
      "age": "0",
      "cache-control": "public, max-age=1, stale-while-revalidate=9",
      "content-type": "application/json;charset=utf-8",
      "date": "Mon, 24 Feb 2025 09:35:28 GMT",
      "referrer-policy": "no-referrer-when-downgrade",
      "server": "ATS",
      "strict-transport-security": "max-age=31536000",
      "vary": "Origin,Accept-Encoding",
      "x-content-type-options": "nosniff",
      "x-envoy-decorator-operation": "finance-company-fundamentals-api--mtls-production-ir2.finance-k8s:4080/*",
      "x-envoy-upstream-service-time": "2",
      "x-frame-options": "SAMEORIGIN",
      "x-xss-protection": "1; mode=block",
      "y-rid": "0smsq4pjrofb0"
    },
    "bodyJson": {
      "quoteSummary": {
        "result": [
          {
            "summaryProfile": {
              "address1": "1 North Waukegan Road",
              "city": "North Chicago",
              "state": "IL",
              "zip": "60064-6400",
              "country": "United States",
              "phone": "847 932 7900",
              "website": "https://www.abbvie.com",
              "industry": "Drug Manufacturers - General",
              "industryKey": "drug-manufacturers-general",
              "industryDisp": "Drug Manufacturers - General",
              "sector": "Healthcare",
              "sectorKey": "healthcare",
              "sectorDisp": "Healthcare",
              "longBusinessSummary": "AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Beh√ßet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",
              "fullTimeEmployees": 55000,
              "companyOfficers": [],
              "executiveTeam": [],
              "maxAge": 86400
            }
          }
        ],
        "error": null
      }
    }
  }
}